Next Article in Journal
Therapeutic Efficacy of ABN401, a Highly Potent and Selective MET Inhibitor, Based on Diagnostic Biomarker Test in MET-Addicted Cancer
Previous Article in Journal
New Therapeutics in HER2-Positive Advanced Breast Cancer: Towards a Change in Clinical Practices?
 
 
Article

Article Versions Notes

Cancers 2020, 12(6), 1574; https://doi.org/10.3390/cancers12061574
Action Date Notes Link
article xml file uploaded 14 June 2020 13:30 CEST Original file -
article xml uploaded. 14 June 2020 13:30 CEST Update -
article pdf uploaded. 14 June 2020 13:30 CEST Version of Record https://www.mdpi.com/2072-6694/12/6/1574/pdf-vor
article supplementary file uploaded. 14 June 2020 13:30 CEST - https://www.mdpi.com/2072-6694/12/6/1574#supplementary
article html file updated 14 June 2020 13:31 CEST Original file -
article xml file uploaded 14 June 2020 13:37 CEST Update -
article xml uploaded. 14 June 2020 13:37 CEST Update -
article pdf uploaded. 14 June 2020 13:37 CEST Updated version of record https://www.mdpi.com/2072-6694/12/6/1574/pdf-vor
article html file updated 14 June 2020 13:38 CEST Update -
article xml file uploaded 15 June 2020 13:36 CEST Update -
article xml uploaded. 15 June 2020 13:36 CEST Update https://www.mdpi.com/2072-6694/12/6/1574/xml
article pdf uploaded. 15 June 2020 13:36 CEST Updated version of record https://www.mdpi.com/2072-6694/12/6/1574/pdf
article html file updated 15 June 2020 13:38 CEST Update -
article html file updated 7 July 2020 15:08 CEST Update -
article html file updated 21 July 2022 20:51 CEST Update https://www.mdpi.com/2072-6694/12/6/1574/html
Back to TopTop